The Plasticity of CD4⁺CD25⁺FOXP3⁺CD127^low T Cells in Patients with Metastatic Renal Cell Carcinoma in the Course of Interferon-Alpha Immunotherapy

Figure 1

Absolute number (a) and percentage ((b) and (c)) of Treg cells in peripheral blood of patients with mRCC before, 2 weeks, and 2 months after IFN-α immunotherapy.

(a)

(b)

(c)